PRAX-562

About Praxis Precision Medicines

Praxis Precision Medicines is a clinical-stage biotech company with a mission to revolutionize neurology by developing precision therapies for CNS disorders, leveraging a proprietary platform built on human genetics, translational tools, patient-guided development, and rigorous clinical paths. The company has achieved significant valuation growth, driven by a promising pipeline targeting rare genetic epilepsies, essential tremor, and focal seizures, with multiple late-stage clinical programs underway. Its strategy focuses on de-risking development through genetic validation and efficient trial designs to address devastating, high-unmet-need conditions.

Therapeutic Areas